GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors -- Barrons.com
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Genedx Holdings Insider Sold Shares Worth $394,733, According to a Recent SEC Filing
Small-cap Stocks Have Climbed Recently. Here Are the Ones Most Poised for Further Upside
GeneDx Holdings Corp.'s (NASDAQ:WGS) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 12% Over the Past Week